Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/19/25 16:11 | 5/15/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Albini Edward C | CA | O | CFO,Secr | 1 | M.d | 0 | 0.00 | 0 | 45 | 39 | 161 | D | ||||||||||||||
5/5/25 17:48 | 5/1/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Fitzpatrick Linda A | CA | O | Chief Pe | 1 | M.d | 0 | 0.00 | 0 | 38 | 41 | 130 | D | ||||||||||||||
5/5/25 17:46 | 5/1/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Srinivasan Venkatesh | CA | O | Chief Te | 2 | M.d | 0 | 0.00 | 0 | 24 | 79 | 54 | D | ||||||||||||||
5/5/25 17:45 | 5/1/25 | STRO | Health | BioPrd | Biological Products, (No Diag | Borgman Anne Elizabeth | CA | O | Chief Me | 1 | M.d | 0 | 0.00 | 0 | 69 | 243 | 97 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |